LE vs REGN · P/E 63, rev $1.15B vs P/E 14, rev $14.34B
Lands’ End Inc (LE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Lands’ End Inc (LE) is a apparel retail company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported LE revenue for 2025-01-31 was $1.15B. Net income was $6.2M. LE currently screens at market cap $347.1M and trailing P/E 62.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
LE currently screens at market cap $347.1M and trailing P/E 62.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the LE and REGN stock pages for the full models.
Not investment advice.